Sustiva (Efavirenz)

(℞) Prescription Required

Top Brand Choice
Top Generic Choice

Sustiva 50mg

Product of United Kingdom
Manufactured by: Bristol-Myers Squibb
*Product image for reference use only.
Select Quantity
Sustiva 50mg
Product of United Kingdom
Manufactured by Bristol-Myers Squibb
Top Brand Choice
Top Generic Choice

Sustiva 100mg

Product of United Kingdom
Manufactured by: Bristol-Myers Squibb
*Product image for reference use only.
Select Quantity
Sustiva 100mg
Product of United Kingdom
Manufactured by Bristol-Myers Squibb
Top Brand Choice
Top Generic Choice

Sustiva 200mg

Product of Australia
Manufactured by: Merck Sharp & Dohme
*Product image for reference use only.
Sustiva is also marketed as Stocrin
Select Quantity
Sustiva 200mg
Product of Australia
Manufactured by Merck Sharp & Dohme
Top Brand Choice
Top Generic Choice

Sustiva 600mg

Product of New Zealand
Manufactured by: Merck Sharp & Dohme
*Product image for reference use only.
Sustiva is also marketed as Stocrin
Select Quantity
Sustiva 600mg
Product of New Zealand
Manufactured by Merck Sharp & Dohme
Top Brand Choice
Top Generic Choice

Sustiva 50mg

Product of Canada
Manufactured by: Bristol-Myers Squibb
*Product image for reference use only.
Select Quantity
Sustiva 50mg
Product of Canada
Manufactured by Bristol-Myers Squibb
Top Brand Choice
Top Generic Choice

Sustiva 200mg

Product of Canada
Manufactured by: Bristol-Myers Squibb
*Product image for reference use only.
Select Quantity
Sustiva 200mg
Product of Canada
Manufactured by Bristol-Myers Squibb
Top Brand Choice
Top Generic Choice

Sustiva 600mg

Product of Canada
Manufactured by: Bristol-Myers Squibb
*Product image for reference use only.
Select Quantity
Sustiva 600mg
Product of Canada
Manufactured by Bristol-Myers Squibb
Top Brand Choice
Top Generic Choice

Efavirenz 600mg

Product of Canada
Manufactured by: Teva Pharmaceuticals
*Product image for reference use only.
Select Quantity
Efavirenz 600mg
Product of Canada
Manufactured by Teva Pharmaceuticals
Top Brand Choice
Top Generic Choice

Efavirenz 200mg

Product of India
Manufactured by: Emcure Pharma
*Product image for reference use only.
Select Quantity
Efavirenz 200mg
Product of India
Manufactured by Emcure Pharma
Top Brand Choice
Top Generic Choice

Efavirenz 600mg

Product of India
Manufactured by: Cipla Ltd
*Product image for reference use only.
Select Quantity
Efavirenz 600mg
Product of India
Manufactured by Cipla Ltd
Select your dosage

Sustiva (Efavirenz) Dosage and Side Effects

Your doctor has prescribed SUSTIVA for you because you have been infected with HIV. SUSTIVA fights Human Immunodeficiency Virus (HIV) infection by reducing the amount of virus in the blood (called “viral load”).

Warnings and Precautions

Before Taking SUSTIVA:

What should I tell my doctor before I start SUSTIVA?

  • Inform your doctor about any past or present medical problems, including liver disease, hepatitis, allergies, severe kidney failure, seizures or mental illness.
  • Inform your doctor if you have ever had a previous life-threatening skin reaction (e.g. Stevens-Johnson syndrome).
  • Inform your doctor about any medications (prescription and nonprescription), herbal products, vitamins, nutritional supplements that you are currently taking or are planning to take.
  • Also inform your doctor about any recreational (street, illicit) drugs that you are currently taking or are planning to take. The effect of combining recreational (street, illicit) drugs or alcohol with SUSTIVA has not been studied. Because they may interact with each other, speak with your doctor or other health care provider before you combine these drugs.

What should I consider concerning contraception, pregnancy, or breast-feeding?

  • Tell your doctor if you are pregnant or planning to become pregnant. Birth defects have been reported in the offsprings of animals and women treated with SUSTIVA during pregnancy. It is not known whether SUSTIVA caused these defects. Women should not become pregnant while taking SUSTIVA and for 12 weeks after stopping it. If you are pregnant, you should take SUSTIVA only if you and your doctor decide that the possible benefit to you is greater than the possible risk to your fetus. If you take SUSTIVAwhile you are pregnant, talk to your doctor about how you can be included in the antiretroviral pregnancy registry.
  • Tell your doctor if you are breastfeeding or planning to breastfeed. It is currently recommended that HIV-infected women should not breastfeed. Discuss this with your doctor.
  • A reliable form of barrier contraception must always be used even if you or your partner are using other methods of contraception such as the pill or other hormonal therapy (e.g., implants, injections). SUSTIVA may remain in your blood for a time after therapy is stopped. Therefore, you should continue use of a reliable form of contraception for 12 weeks after stopping treatment with SUSTIVA.

Can children take SUSTIVA?

  • SUSTIVA has not been studied in children below 3 years of age.
  • SUSTIVA can be taken by children 3 years or older and who are able to swallow capsules. Your child's doctor will determine the right dose based on your child's weight.

Do not drive or operate machinery until you have determined your response to SUSTIVA, as this may make you sleepy or dizzy.

Side Effects

  • SUSTIVA, like all medications, affects different people in different ways. Any medication may have unintended or unwanted effects, so-called side effects. Some people may develop side effects, others may not.
  • The most notable side effects of SUSTIVA are rash and nervous system symptoms that include dizziness, insomnia (difficulty falling asleep), drowsiness, reduced ability to concentrate, and abnormal dreaming. These side effects are generally mild to moderate and tend to disappear after you have taken SUSTIVA for a few weeks. Decreasing the dose does not seem to help and is not recommended.
  • Some of these side effects such as dizziness will likely be less noticeable if you take SUSTIVA before going to bed. Be sure to tell your doctor if any of these side effects continue or if they bother you.
  • A small number of patients have had severe depression, strange thoughts, or angry behavior. Some patients have had thoughts of suicide and a few patients have actually committed suicide. These problems tend to occur more often in patients with a history of mental illness. You should contact your doctor immediately if you think you are having these symptoms, so your doctor can decide whether you should continue to take SUSTIVA.
  • Dizziness, trouble concentrating, and drowsiness have been reported with SUSTIVA. If you notice any of these symptoms you should avoid potentially hazardous tasks such as driving or operating machinery.
  • You should consult your doctor if you have a rash since some rashes may be serious. However, most cases of rash disappear without any change in your treatment.
  • Rash seems to be more common in children than in adults treated with SUSTIVA.
  • Changes in body fat have been seen in some patients taking antiretroviral therapy. These changes may include increased amount of fat in the upper back and neck (“buffalo hump”), breast, and around the trunk. Loss of fat from the legs, arms, and face may also happen. The cause and long-term health effects of these conditions are not known at this time.
  • Some patients taking SUSTIVA have experienced serious liver problems including liver failure resulting in transplantation or death. Most of these serious side effects occurred in patients with a chronic liver disease such as a hepatitis infection, but there have also been a few reports in patients without any existing liver disease.
  • Changes in your immune system (Immune Reconstitution Inflammatory Syndrome) can happen when you start taking HIV medicines. Your immune system may get stronger and begin to fight infections that have been hidden in your body for a long time, or you could develop an autoimmune disease in which your immune system reacts against your own body (e.g. Graves' disease (which affects the thyroid gland), Guillain-Barré syndrome (which affects the nervous system) or polymyositis (which affects the muscles) and it may develop at any time, sometimes months later after the start of HIV therapy). Sometimes symptoms can be severe, so if you develop high temperature (fever), joint or muscle pain, redness, rash, swelling, or fatigue or any new symptoms contact your doctor straight away.

Other side effects:

  • Other common side effects that have been reported include tiredness, nausea, diarrhea and headache. These may be from SUSTIVA or from other medications that you are taking.
  • Tell your doctor or other health care provider if you notice these or any other side effects not mentioned in the pamphlet that continue or if they bother you.

Remember do not stop taking SUSTIVA without speaking to your doctor first. He or she may be able to help you manage these side effects without stopping your anti-HIV medications.

Interactions with this medication

Drugs that may interact with SUSTIVA:

SUSTIVA may affect the dosing of other medications including ones for treating HIV infection. For this reason it is very important to:

  • Let all health care providers know that you are taking SUSTIVA.
  • Inform your doctor and pharmacist about all medications that you are currently taking including those obtained over-the-counter without a prescription and complementary medications (vitamins, nutritional supplements, etc.) and herbal products, particularly St. John's wort.
  • Consult your doctor or pharmacist before you start any new medication.
  • Consult your doctor or pharmacist before you stop any medications that you are currently taking.

Bring all your medications when you see your doctor. Or make a list of their names, how much you take, and how often you take them. This will give your doctor a complete picture of the medications you are taking. Then he or she can decide the best approach for your situation.

You must not take the following medications if you are taking SUSTIVA. Taking these medications with SUSTIVA could create the potential for serious and/or life-threatening side effects:

CISAPRIDE

MIDAZOLAM

TRIAZOLAM (e.g, HALCION)

ERGOT MEDICATIONS (e.g, CAFERGOT)

PIMOZIDE (e.g, ORAP)

  1. JOHN’S WORT (Hypericum perforatum): You must not take products containing St. John’s wort (Hypericum perforatum) with SUSTIVA as this may stop SUSTIVA from working properly and may lead to resistance to SUSTIVA or resistance to the class of non-nucleoside reverse transcriptase inhibitors (NNRTIs).

The following drugs may interact with SUSTIVA and your doctor will determine whether they can be used or not or may make dosage changes for SUSTIVA or the other product, or substitute other products, as indicated below:

  • SUSTIVA may be taken with many of the medications commonly used in people with HIV infection. These include the protease inhibitors, such as nelfinavir (Viracept) and indinavir (Crixivan), and nucleoside analogue reverse transcriptase inhibitors (NRTIs).
  • Use of SUSTIVA with saquinavir (Invirase) is not recommended if you are taking saquinavir as your only protease inhibitor.
  • VORICONAZOLE (VFEND) should not be taken at standard doses with SUSTIVA since it may lose its effect or increase the chance of side effects from SUSTIVA. Some doses of voriconazole can be taken at the same time as a lower dose of SUSTIVA, but your doctor will decide if this is appropriate.
  • Tegretol (carbamazepine), Sporanox (itraconazole), Posanol (posaconazole) and REYATAZ (atazanavir sulfate), if this is not the first time you are receiving treatment for your HIV infection, may need to be replaced with another medicine when taken with SUSTIVA.
  • SUSTIVA reduces the blood levels of clarithromycin (Biaxin) and is associated with a higher incidence of rash; your doctor may consider giving you an alternative antibiotic.
  • If you are taking SUSTIVA and REYATAZ (atazanavir sulfate), you should also be taking Norvir (ritonavir).
  • SUSTIVA reduces exposure of Galexos (simeprevir) and coadministration is not recommended; your doctor should consider alternatives.
  • Antimalarials such as atovaquone/proguanil, when taken with SUSTIVA, may reduce the amount of atovaquone/proguanil in your blood which may reduce the antimalarial activity of these medicines. Atovaquone/proguanil should not be taken with SUSTIVA; your doctor should consider alternatives to these antimalarial medicines.

The following medicine should not be taken with SUSTIVA since it contains efavirenz, the active ingredient in SUSTIVA:

  • ATRIPLA (efavirenz, emtricitabine, tenofovir disoproxil fumarate) unless your doctor decides a dose adjustment is needed (e.g., with rifampin).
  • Your doctor may need to adjust the dose of either SUSTIVA or the following medications when taken with SUSTIVA:
    • Crixivan (indinavir)
    • Methadone
    • Zoloft (sertraline)
    • Wellbutrin SR, Wellbutrin XL, or Zyban (bupropion)
    • Kaletra (lopinavir/ritonavir): Lopinavir and ritonavir combination should not be taken once daily with SUSTIVA. Your doctor may suggest an alternate dosing regimen.
    • Celsentri (maraviroc)
    • Mycobutin (rifabutin)
    • The cholesterol-lowering medicines Lipitor (atorvastatin), Pravachol (pravastatin), and Zocor (simvastatin)
    • Rifadin (rifampin) or the rifampin-containing medicines Rofact and Rifater
    • Calcium channel blockers such as Cardizem or Tiazac (diltiazem), Covera HS, Isoptin SR or Tarka (verapamil), and others
    • Immunosuppressants such as Neoral (cyclosporin), Advagraf or Prograf (tacrolimus), Rapamune or Torisel (sirolimus)
    • Hepatitis C antiviral agents such as Victrelis (boceprevir) and Incivek (telaprevir)
    • Antimalarials such as Coartem and Riamet (artemether/lumefantrine)
  • The effect of combining alcohol or recreational (street, illicit) drugs with SUSTIVA has not been studied. Because they may interact with each other, speak with your doctor or other health care provider before you combine these drugs.

Proper Use of this medication

Usual dose:

  • The dose of SUSTIVA for adults and children weighing more than 40 kg (88 lbs) is 600 mg once-a-day (three 200 mg capsules taken together OR one 600 mg tablet).
  • The dose for children weighing 40 kg or less is determined by the weight of the child and is taken once daily. SUSTIVA capsules should only be administered to children if they have the ability to reliably swallow capsules.
  • You should take SUSTIVA on an empty stomach, preferably at bedtime. Taking SUSTIVA with food increases the level of efavirenz in the blood and may increase the possibility of side effects.
  • Your doctor or pharmacist will give you instructions for proper dosage.

What should I remember to do or avoid while taking SUSTIVA?

  • Swallow SUSTIVA with water.
  • Do not chew the capsules or tablets.
  • Taking SUSTIVA at bedtime may improve the tolerability of the nervous system side effects.
  • It is important to take SUSTIVA as your doctor prescribes. Do not change the dose on your own.
  • SUSTIVA should not be used alone to treat HIV. SUSTIVA should always be taken with other anti-HIV medications in order to prevent the virus from becoming resistant to your drug treatment.
  • You should not stop taking SUSTIVA without first consulting with your doctor.
  • If you are unsure of what to do or need help in planning the best times to take your medications, ask your doctor or other health care provider.
  • If you think it would be useful, ask a friend or family member to remind you to take your medications.
  • When your SUSTIVA supply starts to run low, get more from your doctor or pharmacist. This is very important because the amount of virus may start to increase if SUSTIVA is stopped for even a short time. The virus may then become harder to treat.
  • Remember, SUSTIVA has been prescribed just for you. Never give your medications to others to try.
  • Do not use your current supply of SUSTIVA after the end of the month and year shown by the “expiry date” on the bottle.

Overdose:

In case of drug overdosage, contact a healthcare practitioner (e.g. doctor) hospital emergency department or regional poison control centre, even if there are no symptoms.

Missed dose:

  • If you forget to take SUSTIVA, do not double your next dose. Take the missed dose as soon as possible, and then carry on with your regular dosing schedule.
  • Try not to miss a dose. With anti-HIV medications, missing doses or not taking them properly may allow the amount of HIV in your body to increase. HIV may then become resistant. This means that the virus changes or mutates causing a medication to lose its effect.

Other related products

Sign up to receive exclusive discounts & offers, medication updates, & health news delivered to your inbox.

The above information is an educational aid only. It is not intended as medical advice for individual conditions or treatments. Talk to your doctor, nurse or pharmacist before following any medical regimen to see if it is safe and effective for you.

Back to top